• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Biotechnology Consultant To Lead WIPO Global Challenges Division

12/05/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

A leader for the World Intellectual Property Organization Global Challenges Division – tasked with connecting intellectual property to critical issues such as public health, food security, and climate change – has been named more than a year and a half after the division’s creation.

Anatole Krattiger, a citizen of Switzerland, arrived in Geneva recently to take up the position of Director, Global Challenges Division. This division grew out of Director General Francis Gurry’s goal upon taking office in 2008 to “demonstrate the concrete relevance of intellectual property to the global challenges of climate change, desertification, epidemics, access to health care, food security and the preservation of biodiversity.”

Krattiger holds a PhD from Cambridge University in genetics and biochemistry, specialises in agricultural biotechnology, and used to be a farmer in both Switzerland and in southern France, according to a profile [pdf] from Franklin Pierce law school.

More recently, he was a professor in the United States at both the Biodesign Institute at Arizona State University and at Cornell University. At Arizona State he co-taught courses on innovation management and controversies in health and agricultural biotechnology, according to his profile at the university. Also at ASU, he worked on the “intellectual property component of plant derived pharmaceuticals and vaccines,” according to his LinkedIn profile. At Cornell, where he worked for 18 years, he co-taught a course in Patents, Plants and Profits, according to the LinkedIn profile.

Also on the LinkedIn profile, he lists his interests as the “international dimension of technology transfer” and “use of appropriate technologies to alleviate poverty in health and agriculture,” and says that he “manages the global access strategy of a Bill & Melinda Gates Foundation-funded program for the development of pneumonia and meningitis vaccine for newborns.”

Krattiger served as an executive to the Humanitarian Board for GoldenRice, working on licensing, technology transfer, patent pooling and regulatory issues, according to several sources. GoldenRice is controversial rice variety genetically modified to produce higher levels of beta-carotene, necessary for the production of Vitamin A. Questions have been raised about efforts funded by the Rockefeller Foundation and the Swiss government to promote this non-traditional form of rice in the global South, which comes with many patents owned by companies in developed countries. Krattiger consulted for the Rockefeller Foundation on health, agriculture and innovation.

Krattiger assisted in the founding of the International Service for the Acquisition of Agri-Biotech Applications (ISAAA), according to the ASU profile. ISAAA is a non-profit aimed at sharing “the benefits of crop biotechnology to various stakeholders, particularly resource-poor farmers in developing countries, through knowledge sharing initiatives and the transfer and delivery of proprietary biotechnology applications,” according to its website. He consulted for the Rockefeller Foundation on health, agriculture and innovation.

Krattiger is a member of the Advisory Council at Franklin Pierce Law Center in Concord, New Hampshire, a law school specialising in intellectual property; a contributing author to the IP Handbook, an online resource for IP policymakers; president and founder of bioDevelopments-International Institute, a non-profit working in innovation and IP; the editor-in-chief at Innovation Strategy Today; and speaks German, English, French, and Spanish. He has published on a variety of biotechnology matters, from scientific and policy angles.

Other Vacancies at WIPO

WIPO is also searching for new staff in other areas, according to its recruitment page, including: a director for the creators and performers support division in the Copyright and Related Rights Sector and a head of evaluation and inspection at the Internal Audit and Oversight Division.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Kaitlin Mara may be reached at kmara@ip-watch.ch.

Creative Commons License"Biotechnology Consultant To Lead WIPO Global Challenges Division" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Health & IP, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, United Nations - other, WIPO

Comments

  1. anonymous says

    20/12/2010 at 6:59 am

    Biotechnology and Patent challenge:
    Since inception patent law is being customized and fine tuned by governments to meet the needs of evolving technologies. Strong basic principles have evolved to cater to the needs of traditional fields of science and technology and they have been working well in promoting progress. However, the basic principles have utterly failed in a number of ways, when it comes to their application to Modern Biotechnology. The unique nature of Modern Biotechnology is the main reason for the failure.
    Why is Biotechnology Unique?
    Biotechnology promises more…. to read more, click on http://www.sinapseblog.com

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.